EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The anti‐ CRISPR protein AcrIE8 .1 inhibits the type I‐E CRISPR ‐Cas system by directly binding to the Cascade subunit Cas11

Young Woo Kang, Hyun Ho Park iD

FEBS Letters · 2026-02 · 600 (3) · 334-341

DOI: 10.1002/1873-3468.70201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 25.10.2025. Verfasst von Young Woo Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chung-Ang University, Seoul, Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins, Viral Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung-Ang University, National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR‐Cas systems provide adaptive immunity to bacteria by recognizing and destroying foreign genetic elements. The type I‐E CRISPR‐Cas system utilizes a multi‐subunit Cascade complex to detect target DNA and recruit the Cas3 nuclease for degradation. To overcome this defense, bacteriophages have evolved anti‐CRISPR (Acr) proteins that inhibit various steps of the CRISPR interference pathway. Here, we determined the crystal structure of AcrIE8.1, an uncharacterized Acr, revealing it binds to Cas11, a Cascade subunit, to disrupt function. AcrIE8.1 has a compact fold with a defined Cas11‐binding interface, suggesting a unique inhibitory mechanism among AcrIE proteins. These findings highlight Cas11 as a critical target for Acr‐mediated immune evasion. Impact statement Through a combination of structural and biochemical analyses, we demonstrate that AcrIE8.1 directly binds to the Cas11 subunit of the Cascade complex to inhibit the CRISPR‐Cas system. This represents a novel inhibitory strategy not previously observed among AcrIE proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsCRISPR-Associated ProteinsViral ProteinsProtein BindingCrystallography, X-RayBacteriophagesModels, Molecular

Stichwörter der Autor:innen

AcrIE8.1CRISPR‐Cas systemanti‐CRISPR proteinscrystal structuregene editing

Substanzen

CRISPR-Associated ProteinsViral Proteins

Autor:innen und Institutionen

  • College of Pharmacy, Chung-Ang University, Seoul, Korea.
  • Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Korea.

ORCID-Profile: Hyun Ho Park

Förderung

  • Chung-Ang University
  • National Research Foundation of Korea (NRF)

Zitieren

APA

Kang, Y. W., & Park, H. H. (2026). The anti‐ CRISPR protein AcrIE8 .1 inhibits the type I‐E CRISPR ‐Cas system by directly binding to the Cascade subunit Cas11. FEBS Letters, 600(3), 334-341. https://doi.org/10.1002/1873-3468.70201

Vancouver

Kang YW, Park HH. The anti‐ CRISPR protein AcrIE8 .1 inhibits the type I‐E CRISPR ‐Cas system by directly binding to the Cascade subunit Cas11. FEBS Letters. 2026;600(3):334-341. doi:10.1002/1873-3468.70201

BibTeX
@article{Kang2026,
  author = {Kang, Young Woo and Park, Hyun Ho},
  title = {The anti‐ CRISPR protein AcrIE8 .1 inhibits the type I‐E CRISPR ‐Cas system by directly binding to the Cascade subunit Cas11},
  journal = {FEBS Letters},
  year = {2026},
  volume = {600},
  number = {3},
  pages = {334--341},
  doi = {10.1002/1873-3468.70201}
}
Kostenlos starten →